{
  "compound": "Dronabinol vs Megestrol vs Combination",
  "condition": "CANCER_PALLIATIVE",
  "effect_size": "Medium for dronabinol (49% response)",
  "study_type": "RCT",
  "source": "NORML:CANCER_RCT_003",
  "participants": "469 patients with cancer anorexia/cachexia",
  "year": 2002,
  "notes": "Dronabinol for Cancer Anorexia: Phase III Trial",
  "confidence": "medium",
  "abstract": "Appetite: Dronabinol 49% vs Megestrol 75% vs Combination 66%; Megestrol superior for appetite, but dronabinol had fewer side effects"
}